Overview the challenges and development of regenerative medicine in future

Mozhdeh Haddadi,1,*



More than 2000clinical trials relating stem cells, there is not a single clinical difficult that is regularly treated with stem cell therapy because it is better than the standard of attention. for all the progress we have prepared in the rapid moving scope of regenerative medicine (rm). have the technologies that we now have at hand, such as bio-printing, microfluidics and photopatterning, that rm development?


? to development the step of growth, scientists are now approving multidisciplinary plans, joining evolutionarily preserved ideologies of growing biology, immunology, stem cell biology, tissue engineering, biomechanics, and medicine in ex vivo and in vitro methods. with the appearance of cell-based therapy as a potential therapeutic plan for tissue regeneration in different chronic conditions, it is imperative that academic courses be instituted to formally train physicians and scientists in the conduct of translational and clinical research, as well as in the technical procedures used in the rm field.


Quick advances in stem cell research have raised the attention of governments, media and patients. clinical achievement depends on factors single to cell therapies, containing manufacturing procedures, clinical and pharmacologic standardisation of protocols and requirements.


An understanding of the regenerative medicine viewpoints will offer an insight into the likely future form of the novel therapies, periods, as well as infrastructural provisions that requisite to be supplied in order to facilitate its unimpeded dispersal by academies and by the novel pharmaceutical industry throughout the world. in summary, rm and tissue engineering is one of the most stimulating interdisciplinary and multidisciplinary investigation areas and is developing progressive over time


Tissue engineering